Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2022-01-11 00:00:00 ET · period of report 2022-01-07 · accession 0001628280-22-000730 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-11 | 2022-01-07 | CLOV | Garipalli Vivek | CEO, Dir, 10% | F - Tax | $3.16 | -1.66M | 1.68M | -50% | -$5.26M |
| D | 2022-01-11 | 2022-01-07 | CLOV | Garipalli Vivek | CEO, Dir, 10% | M - OptEx | — | +3.34M | 3.34M | New | — |
| D | 2022-01-11 | 2022-01-07 | CLOV | Garipalli Vivek | CEO, Dir, 10% | M - OptEx | $0.00 | -3.34M | 13.37M | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class B Common Stock | 2022-01-07 | F | D | 1,664,825 | $3.16 | 1,677,873 | D | — | — | |
| 2 | Common | Class B Common Stock | 2022-01-07 | M | A | 3,342,698 | — | 3,342,698 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. |
| 3 | Derivative | Restricted Stock Unit | 2022-01-07 | M | D | 3,342,698 | $0.00 | 13,370,793 | D | — · — to — | 3,342,698 Class B Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. (F2) On January 7, 2021, the Reporting Person was granted 16,713,491 RSUs, vesting in equal annual installments over five years, beginning on January 7, 2022, subject to the continuous service of the Reporting Person as CEO, Co-CEO or Executive Chairman of the Issuer through each vesting date. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person upon vesting. |